Morberg John D 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Morberg John D
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-01-18−6,283→ 125,617 total - Exercise/Conversion
Restricted Stock Unit
2024-01-18−17,500→ 0 totalFrom: 2024-01-18→ Common Stock (17,500 underlying) - Exercise/Conversion
Common Stock
2024-01-18+17,500→ 131,900 total
Footnotes (2)
- [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
- [F2]The restricted stock units vested on January 18, 2024.